Associations between muscle measures, survival, and toxicity in patients with limited stage small cell lung cancer
Abstract Background Standard treatment for patients with limited stage small cell lung cancer (LS SCLC) is concurrent platinum–etoposide chemotherapy and thoracic radiotherapy (TRT). Up to 30% of patients are cured, but severe toxicity is common, and we are not able to identify those who are cured o...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-10-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.12583 |